Abstract:We have developed a Pd(II) catalyzed direct modification of dihydropyrrolo[2,1‐a]isoquinoline derivatives with various alkenes including acrylates, acrylamide, cyclohexenone, maleimide and styrenes. A series of highly functionalized alkenylated dihydropyrroloisoquinolines could be prepared in acceptable to good yields (up to 98 %) through oxidative Heck coupling.
“…As the straightforward modification of complex N-containing molecules is a convenient way for the preparation of useful architectures, our laboratory have been interested in direct functionalization of a series of privileged framework-bearing molecules (Scheme ). , Recently, we have developed several direct approaches for modifying privileged N-containing frameworks such as iron-mediated dimerization of dihydropyrroloisoquinolines, iron-catalyzed cross coupling of dihydropyrroloisoquinolines with phenols, and palladium-catalyzed olefination of dihydropyrroloisoquinolines …”
We have developed an efficient formylation
of pyrroloisoquinolines
using bromoisobutyrate and dimethyl sulfoxide as carbonyl reagent.
Various formylated pyrroloisoquinolines could be prepared in good
yields (up to 94%). This formylation process can be easily scaled
up to gram scale with good yield. In most cases of pyrroloisoquinolines
without methoxy groups, the combination of bromoisobutyrate and dimethyl
sulfoxide could act as a bromination reagent, delivering brominated
pyrroloisoquinolines in acceptable to good yields (up to 82%).
“…As the straightforward modification of complex N-containing molecules is a convenient way for the preparation of useful architectures, our laboratory have been interested in direct functionalization of a series of privileged framework-bearing molecules (Scheme ). , Recently, we have developed several direct approaches for modifying privileged N-containing frameworks such as iron-mediated dimerization of dihydropyrroloisoquinolines, iron-catalyzed cross coupling of dihydropyrroloisoquinolines with phenols, and palladium-catalyzed olefination of dihydropyrroloisoquinolines …”
We have developed an efficient formylation
of pyrroloisoquinolines
using bromoisobutyrate and dimethyl sulfoxide as carbonyl reagent.
Various formylated pyrroloisoquinolines could be prepared in good
yields (up to 94%). This formylation process can be easily scaled
up to gram scale with good yield. In most cases of pyrroloisoquinolines
without methoxy groups, the combination of bromoisobutyrate and dimethyl
sulfoxide could act as a bromination reagent, delivering brominated
pyrroloisoquinolines in acceptable to good yields (up to 82%).
The advancement of CH/CH cross‐dehydrogenative coupling (CDC) reactions for the construction of C(sp
2
)C(sp
2
) bond with representative examples from mainly 2016 to May 2021 is overviewed. Palladium‐catalyzed CDC reaction has been considered as a modern and attractive synthetic tool due to (i) limited amount of undesired and toxic by‐products; (ii) more straightforward synthetic approach from simple materials, resulting in a better step‐ and atom economy. Diversified applications across pharmaceutical and material areas have been successfully realized. In addition to the ordinary CDC reaction, the most recent accomplishments of asymmetric CDC process are also included.
Palladium‐catalyzed [4+2] oxidative annulation of coumarin‐benzimidazoles with olefins for the synthesis of polycyclic aromatic hydrocarbons have been achieved. This synthetic protocol gives access to a wide range of structurally distinct imidazo[1,2‐a]chromeno[3,4‐c]pyridines in moderate to good yield with wide functional group tolerance. Further, photophysical properties of annulated scaffolds have been examined, which discloses their interesting solvatochromic emission behaviors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.